final program

 

Click here to download Final Program as a pdf.


Saturday,
July 26, 2014
Sunday,
July 27, 2014
Monday,
July 28, 2014
Oral Presentations Oral Presentations Oral Presentations
Poster Sessions Poster Sessions Poster Sessions

 

Monday, July 28, 2014

08:30-11:00   Grand Ballroom
 

PL17    Plenary Session:
DIET, LIFESTYLE AND CVD PREVENTION NEW ORIGINS
 

Chairs:
E. Barrett-Connor, La Jolla, CA, USA
J.L. Mehta,
Little Rock, AR, USA

 
08:30 IS THE DASH DIET THE OPTIMAL DIET FOR HEART FAILURE PATIENTS? (Invited Lecture)
M.A. Silver
Advocate Christ Medical Center, University of Illinois. IL, USA
404
08:45 MEDITERRANEAN DIET AND SECONDARY PREVENTION OF CVD (Invited Lecture)
D.B. Panagiotakos
Harokopio University, Athens, Greece 
405
09:00 LOOKING BACK ON THE LOOK AHEAD TRIAL (Invited Lecture)
E. Barrett-Connor
University of California San Diego, La Jolla, CA, USA
406
09:15 SATURATED FAT INTAKE AND THE GENESIS OF CORONARY ARTERY DISEASE – WHERE’S THE EVIDENCE? (Invited Lecture)
S. Vallurupalli, J.L. Mehta
University of Arkansas for Medical Sciences, Little Rock, AR, USA
407
09:30 INTEGRATING NUTRITION EDUCATION INTO THE CARDIOVASCULAR CURRICULUM CHANGES MEDICAL STUDENT EATING HABITS (Invited Lecture)
R. Zelis, E. Vargas
Pennsylvania State University, Hershey Medical Center, Hershey, PA, USA
408
09:45 DO VITAMIN AND MINERAL SUPPLEMENTS HAVE A ROLE IN CARDIOVASCULAR DISEASE PREVENTION? (Invited Lecture)
H.D. Sesso, Brigham and Women's Hospital, Boston, MA, USA
409
10:00 ALTERNATE HEALTHY EATING INDEX, MEDITERRANEAN AND DASH DIETARY PATTERNS AND RISK OF DEATH IN THE PHYSICIAN'S HEALTH STUDY (Invited Lecture)
L. Djousse, A. Petrone, J.M. Gaziano
Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
410
10:15 RACIAL DIFFERENCES IN VITAMIN D/PARATHYROID HORMONE ENDOCRINE SYSTEM AND CARDIOVASCULAR DISEASE (Invited Lecture)
Y. Song, Indiana University, Indianapolis, IN, USA
411
10:30 DIETARY FATTY ACID COMPOSITION AS A RISK FACTOR FOR CARDIOMETABOLIC DISORDERS: BEYOND THE CALORIES (Invited Lecture)
L. Wang, Brigham and Women's Hospital, Boston, MA, USA
412
10:45 THE ROLE OF EXERCISE AND REHABILITATION FOR HEART FAILURE PATIENTS (Invited Lecture)
C. Chrysohoou, Hippokration Hospital,University of Athens, Greece
413
11:00 COFFEE BREAK, VISIT POSTERS AND EXHIBITION  
MONDAY, July 28, 2014
08:30-10:45   Martha’s Vineyard

 

PL18   Plenary Session:
ADVANCES IN THE TREATMENT AND MANAGEMENT OF HEART FAILURE

Chairs:

P.A. Heidenreich, Palo Alto, CA, USA
V.H. Pitzalis, Greenville, NC, USA

 

08:30 THE MANAGEMENT OF PATIENTS WITH ADVANCED HEART FAILURE (Invited Lecture)
V.H. Pitzalis
East Carolina University, The Brody School of Medicine, Greenville, NC, USA
414
08:45 CAN WE PREVENT HEART FAILURE READMISSIONS? (Invited Lecture)
P.A. Heidenreich
Stanford University, Palo Alto, CA, USA
415
09:00 ROLE OF THE "PERIPHERY" IN HEART FAILURE AND PRESERVED EJECTION FRACTION (Invited Lecture)
J.A. Chirinos
University of Pennsylvania School of Medicine, Philadelphia, PA, USA
416
09:15 CARDIORENAL SYNDROME: NOT AS STRAIGHT FORWARD AS WE USED TO THINK (Invited Lecture)
A. Kazory
University of Florida, Gainesville, FL, USA
417
09:30 NEW TECHNOLOGIES TO IMPROVE CRT OUTCOME (Invited Lecture)
K. Seidl
Klinikum Ingolstadt, Germany
418
09:45 COLCHICINE AND NEW MANAGEMENT STRATEGIES FOR ACUTE AND RECURRENT PERICARDITIS (Invited Lecture)
M. Imazio
Maria Vittoria Hospital, Torino, Italy
419
10:00

SKELETAL MUSCLE HYPERTROPHY INDUCED BY NOVEL KAATSU REHABILITATION AND PREVENTION OF SARCOPENIA (Invited Lecture)
T. Nakajima, T. Yasuda, S. Koide, Y. Sato, T. Morita, T. Tomaru,
Y. Kano
University of Tokyo, Tokyo, Japan

420
10:15 PERICARDIAL INVOLVEMENT FREQUENTLY COMPLICATING PULMONARY AND/OR SYSTEMIC SARCOID GRANULOMATOSIS. A LIFE-LONG, MULTI STAGE DISEASE, PERIODICAL STUDY IN 278 BIOPSY –PROVEN SARCOIDOSIS PATIENTS (Invited Lecture)
I. Angomachalelis, K. George, N. Angomachalelis
G. Papanikolaou General Hospital, Thessaloniki, Greece
421
10:30 IMATINIB: A NOVEL CANDIDATE FOR TREATMENT OF PERMEABILITY EDEMA (Invited Lecture)
G.P. van Nieuw Amerongen
VU University Medical Center, Amsterdam, The Netherlands
422
10:45 COFFEE BREAK, VISIT POSTERS AND EXHIBITION  
MONDAY, July 28, 2014
08:30 - 10:45   Nantucket
  S33   Session:  
THE RELEVANCE OF GENETICS IN PROVIDING UNDERSTANDING AND TREATMENT FOR CARDIOVASCULAR DISEASE

Chairs:
M.J. Sanz, Valencia, Spain
M. Zahid, Pittsburgh, PA, USA
 
08:30 PHARMACOGENETICS-GUIDED INDIVIDUAL WARFARIN DOSING IN A CARDIOLOGY CLINIC – A PERSPECTIVE OBSERVATORY STUDY
W.Q. Fan, Y. Wu, B. Khalighi, A. Mirabbasi, R. Thachil, E.J. Mascarenhas,
K. Khalighi
Easton Hospital, Drexel University, Easton, PA, USA
423
08:45 A MICRO-RNA-410 REGULATED LIPOPROTEIN LIPASE POLYMORPHISM IS ASSOCIATED WITH TRIGLYCERIDES AND STROKE INCIDENCE
D. Corella, O. Coltell, J.V. Sorli, R. Estruch, M. Fito, F. Aros, E. Ros,
J. Lapetra, G.T. Saez, J.M. Ordovas
Instituto de Salud Carlos III, Madrid, Spain
424
09:00 ATF3 PROTECT AGAINST PRESSURE OVERLOAD HEART FAILURE VIA BECLIN-1 PATHWAY
C.F. Cheng, S.F. Li, H. Lin
Tzu Chi General Hospital, Hualien, Taiwan
425
09:15 RAPID UP-REGULATION AND CLEARANCE OF DISTINCT CIRCULATING MICRORNAS AFTER PROLONGED AEROBIC EXERCISE
A.L. Baggish, J. Park, P-K.Min, S. Isaacs, B.A. Parker, P.D. Thompson,
C. Troyanos, P. D’Hemecourt, S. Dyer, M. Thiel, A. Hale, S.Y. Chan
Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
426
09:30 RANOLAZINE PREVENTS TRASTUZUMAB-CARDIOTOXICITY IN EXPERIMENTAL MODELS
N. Maurea, C. Coppola, G. Piscopo, D. Rea, C. Maurea, F. Galletta,
E. Esposito, I. Capasso, P. Maiolino, C. Arra
National Cancer Institute Pascale Foundation IRCCS, Naples, Italy
427
09:45 VARIATION IN THE MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 6 GENE, DAIRY INTAKE AND CARDIOVASCULAR RISK
O. Coltell, C. Ortega-Azorin, M.A. Martinez-Gonzalez, J. Salas-Salvado,
L. Serra-Majem, E. Gomez-Gracia, V. Ruiz-Gutierrez, M. Fiol, X. Pinto,
D. Corella
Instituto de Salud Carlos III, Madrid, Spain
428
10:00 GENE ELECTRO TRANSFER OF PVEGF INDUCES ANGIOGENESIS AND IMPROVES CARDIAC FUNCTION IN A PORCINE ISCHEMIA MODEL
B. Hargrave, R. Strange, Jr., C. Lundberg, N. Burcus, A. Bulysheva,
R. Heller
Old Dominion University, Norfolk, VA, USA
429
10:15 THE FAMILY HISTORY AND GENETIC RISK DISCONNECT IN WOMEN
B.T. Costello, R. Doukky, G.P. Lundberg, L.T. Braun, A.S. Volgman
Rush University Medical Center, Chicago, Illinois, USA
430
10:30 REPETITIVE APPLICATION OF RESTRICTION OF MUSCLE BLOOD FLOW
ENHANCES MTOR SIGNALING PATHWAYS IN A RAT MODEL 
T. Nakajima, T. Yasuda, S. Koide, Y. Sato, T. Tomaru, Y. Kano
University of Electro-Communications, Tokyo, Japan
431
10:45 COFFEE BREAK, VISIT POSTERS AND EXHIBITION  
MONDAY, July 28, 2014
11:15 - 14:00   Grand Ballroom
  PL19   Plenary Session:  
CURRENT CONCEPTS AND FUTURE DIRECTIONS IN ISCHEMIC HEART DISEASE AND ACUTE CORONARY SYNDROME

Chairs:

J.M. Gardin, Hackensack, NJ, USA
U. Thadani, Oklahoma City, OK, USA

 
11:15 OLD AND EMERGING OPTIONS FOR TREATMENT OF REFRACTORY ANGINA: A CRITICAL APPRAISAL (Invited Lecture)
U. Thadani
University of Oklahoma Health Sciences Center and VA Medical Center, Oklahoma City, OK, USA
432
11:30 MANAGEMENT OF STABLE ISCHEMIC HEART DISEASE: OVERVIEW OF RECENT GUIDELINES (Invited Lecture)
J.M. Gardin
Hackensack University Medical Center, NJ, USA
433
11:45 IN-VIVO RISK STRATIFICATION OF INDIVIDUAL CORONARY ARTERY PLAQUES: EVOLVING PARADIGM FOR PREEMPTIVE MANAGEMENT OF PATIENTS WITH CAD (Invited Lecture)
P.H. Stone
Brigham & Women's Hospital, Boston, MA, USA
434
12:00 FRACTIONAL FLOW RESERVE (FFR) AT 2014- WHERE ARE WE AND WHERE IS IT GOING (Invited Lecture)
E. Kaluski
University Hospital, Newark, NJ, USA
435
12:15 IS ISCHEMIA UNIVERSAL IN A CHRONIC TOTAL OCCLUSION? (Invited Lecture)
R. Sachdeva
North Fulton Hospital, Roswell, GA, USA
436
12:30 OPTIMAL DURATION OF DUAL ANTIPLATELET THERAPY AFTER DES IMPLANTATION: EXCELLENT TRIAL AND FUTURE PERSPECTIVES (Invited Lecture)
H-C. Gwon
Sungkyunkwan University School of Medicine, Seoul, Republic of Korea 
437
12:45 DUAL UTILIZATION OF EXERCISE ECHOCARDIOGRAMS AND MYOCARDIAL PERFUSION IN ASSESSING ISCHEMIA IN A CARDIOLOGY PRACTICE (Invited Lecture)
Y. Charuzi, R.W. Gao, J. Mirocha
Cedars Sinai Heart Institute, Los Angeles, CA, USA
438
13:00 ATYPICAL AND UNUSUAL CLINICAL PRESENTATIONS OF PATIENTS WITH ISCHEMIC HEART DISEASE (Invited Lecture)
H.K. Reddy, R. Komatireddy, R.K. Sharma
St. Louis University Medical School, St. Louis, Missouri, USA
439
13:15 STABLE ISCHEMIC HEART DISEASE: EVOLVING CONCEPTS AND THE ROLE OF ISCHEMIA (Invited Lecture)
M.S. Sidhu
Albany Medical College, Albany, NY, USA
440
13:30 CT FLOW METRICS BASED ON CONTRAST OPACIFICATION
F.J. Rybicki, D.M. Mitsouras
Applied Imaging Science Lab, Brigham and Women's Hospital, Boston, MA, USA
442
13:45 SHOULD DUAL ANTI-PLATELET THERAPY FOR CORONARY ARTERY DISEASE BE MORE OR LESS THAN 12 MONTHS? : A META-ANALYSIS
D. Garcia, M. Ansari, C. Martinez, C. Alfonso, A. Benjo, M. Cohen,
E. De Marchena
University of Miami/Jackson Memorial Hospital, Miami, FL, USA
441
MONDAY, July 28, 2014
11:15-13:00   Martha’s Vineyard
 

PL20   Plenary Session:  
OBESITY, DIABETES AND CVD
 

Chairs:
T.B. Levine, Philadelphia, PA, USA

 
11:15 THE MACROPHAGE A2B ADENOSINE RECEPTOR REGULATES OBESITY-INDUCED TISSUE INSULIN SENSITIVITY (Invited Lecture)
K. Ravid, H. Johnston-Cox, A. Eisenstein, M. Koupenova-Zamor
Boston University School of Medicine, Boston, MA, USA
443
11:30 METABOLIC SYNDROME CRITERIA: CAUSE VERSUS EFFECT OF CARDIOMETABOLIC DISEASE (Invited Lecture)
T.B. Levine
Drexel University College of Medicine, Philadelphia, PA, USA
444
11:45 MITOCHONDRIAL DYSFUNCTION AND DIABETIC HEART DISEASE (Invited Lecture)
S. Kobayashi, Y. Huang, Q. Liang
New York Institute of Technology, Old Westbury, NY, USA 
445
12:00 BENEFIT AND RISKS OF ANTIDIABETIC TREATMENT IN PATIENTS WITH CORONARY ARTERY DISEASE AND HEART FAILURE (Invited Lecture)
C.H. Saely
VIVIT Institute, Academic Teaching Hospital, Feldkirch, Austria
446
12:15 SERENDIPITY IN MEDICINE; DOES CHANCE TRULY FAVOR THE PREPARED MIND? (Invited Lecture)
R.W.W. Biederman
Carnegie Mellon University, Allegheny General Hospital, Pittsburgh, PA, USA
447
12:30 HIGH CARDIOVASCULAR RISK IN NON-ALCOHOLIC FATTY LIVER DISEASE: A POSSIBLE ROLE FOR INCREASED OXIDATIVE STRESS? 
F. Angelico, M. Del Ben, L. Polimeni, F. Baratta, D. Pastori, R. Carnevali,
S. Bartimoccia, F. Violi
Sapienza University, Rome, Italy
448
12:45 IMPACT OF METABOLIC SYNDROME ON SUBCLINICAL ATHEROSCLEROSIS IN ASYMPTOMATIC INDIVIDUALS
S.M. Jung, G.M. Park, C.J. Kim, J.S. Cho, M.W. Park, S.H. Her, S.W. Lee
Daejeon St. Mary's Hospital, the Catholic University of Korea, Daejeon, Korea
449
MONDAY, July 28, 2014
11:15-14:00   Adrienne Salon

 

S34   Session:
DISEASE PATHWAYS AND NEW TREATMENT STRATEGIES IN HEART FAILURE AND CARDIOMYOPATHIES

Chairs:

J.A. Chirinos, Philadelphia, PA, USA 
A.M. Gerdes, Old Westbury, NY, USA


 

11:15 TREATING RAPID ATRIAL FIBRILLATION IN DECOMPENSATED HEART FAILURE: METOPROLOL IS SUPERIOR TO DILTIAZEM
F. Katchi, S. Nagabandi, J. Shuster, E. Novak, S. Joseph
Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA
450
11:30 PREDICTORS OF HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF)
A. Kumar, A.K. Saluja, A. Khan, D. Gandhi, M.A. Morsy, W.I. Khalife
University of Texas Medical Branch, Galveston, TX, USA
451
11:45 OPTIMIZING HEART FAILURE OUTCOMES: WHICH HOSPITAL CARE MODEL CAN WE LEARN FROM?
P.M. Ndunda, M. Farhoud, H. Farhoud, K.J. Kallail
Kansas University School of Medicine-Wichita, Wichita, KS, USA
452
12:00 COMPARATIVE EFFECTIVENESS OF TRANSITIONAL CARE SERVICES IN PATIENTS DISCHARGED FROM THE HOSPITAL WITH HEART FAILURE (HF):  A META-ANALYSIS
H.G.C. Van Spall, O. Mytton, M. Coppiens, T. Shiga, B. Haynes, S. Connolly
Population Health Research Institute and McMaster University, Hamilton, Ontario, Canada
453
12:15 INFLUENCE OF PREHYPERTENSION AND STAGE-1 HYPERTENSION ON THE OUTCOME OF ADULTS WITH HYPERTROPHIC CARDIOMYOPATHY
Y.R. Manda, L.B. Chebrolu, J. Shirani
St Luke's University Health Network, Bethlehem, PA, USA
454
12:30 ASSOCIATION OF HUMANIN A NOVEL MITOCHONDRIAL DERIVED PROTEIN AND HUMAN HEART FAILURE: RESULTS OF A PILOT INVESTIGATION
H. Narayanasamy, N. Bardia, J. Wan, D. Lee, P. Cohen, L. Grazette
Keck Medical School of USC, LA, CA, USA
455
12:45 DECREASED RENAL FUNCTION IS ASSOCIATED WITH HEART FAILURE READMISSION
M.R. Vindhyal, B. Duran, H. Farhoud, K.J. Kallail
KU School of Medicine, Wichita, Kansas, USA
456
13:00 EDHFIC: INITIAL EXPERIENCE WITH A NOVEL MULTIDISCIPLINARY COLLABORATION TO DECREASE HEART FAILURE ADMISSIONS
A.S. Bhatt, C. Cosgrove, M. Moorer, A.J. Smally, J. Radojevic, D. Wencker,
J.A. Gluck
University of Connecticut School of Medicine, Farmington, CT, USA
457
13:15 COLCHICINE USE FOR THE PRIMARY PREVENTION OF POSTPERICARDIOTOMY SYNDROME (CUPP): A META-ANALYSIS
C.K. Fomaneg, P.E.E Samonte, M.M. Sasondoncillo-Nadal,
C.L.L Sim-Apura, L.P. Padua
Philippine Heart Center, Quezon City, Philippines
458
13:30 TRASTUZMAB CARDIOTOXICITY DOCUMENTED BY SERIAL ASSESSMENT OF LEFT VENTRICULAR SYSTOLIC FUNCTION AND GLOBAL LONGITUDIANL PEAK STRAIN
A.M. Cook, R.C. Phillion, K.J. Babbitt, L.L. Eberhart, D.E. Langholz,
H.L. Sherman
Spectrum Health Frederik Meijer Heart & Vascular Institute, Grand Rapids, MI, USA
459
13:45 PREDICTORS OF LEFT VENTRICULAR DYSFUNCTION AFTER ARTERIAL-VENOUS FISTULA PLACEMENT
R. Dhingra, S. Tariq, J. Anderson, M. Gallichio, M. Torosoff
Albany Medical College, Albany, NY, USA
460
 

 

Saturday,
July 26, 2014
Sunday,
July 27, 2014
Monday,
July 28, 2014
Oral Presentations Oral Presentations Oral Presentations
Poster Sessions Poster Sessions Poster Sessions

Affiliated with

 

    international academy of cardiology

Endorsed by